医学
酒渣鼻
皮肤病科
异维甲酸
溴莫尼定
不利影响
甲硝唑
安慰剂
痤疮
抗生素
药理学
外科
替代医学
病理
眼压
微生物学
生物
作者
Esther J van Zuuren,Zbys Fedorowicz
出处
期刊:JAMA
[American Medical Association]
日期:2015-12-08
卷期号:314 (22): 2403-2403
被引量:47
标识
DOI:10.1001/jama.2015.15287
摘要
CLINICAL QUESTION: Which interventions are associated with highest efficacy and fewest adverse events for treating rosacea? BOTTOM LINE: There is high-quality evidence that topical brimonidine, azelaic acid, and ivermectin, as well as oral doxycycline and isotretinoin, are associated with improvements in rosacea. Lower-quality evidence is available for topical metronidazole, oral tetracycline, laser and light-based therapy, and topical cyclosporine for ocular rosacea. Most treatments are not associated with higher adverse event rates than placebo.
科研通智能强力驱动
Strongly Powered by AbleSci AI